Dong-A Pharmaceutical동아제약
000640 · KOSPI · ₩000640 · 동아제약
₩86,900▲ ₩600 (0.70%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Major management matter relevant to investors투자판단관련주요경영사항(자회사의 주요경영사항) (제2형 당뇨병 치료 복합제 슈가엠파정 국내 품목허가 승인)Oct 30, 2026Open on DART
Predicted impact: Low
Domestic approval of a type 2 diabetes combination drug; no revenue size given, likely modest impact.
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Oct 27, 2026Open on DART
Predicted impact: Low
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Oct 27, 2026Open on DART
Predicted impact: Medium
Preliminary annual earnings released; size of surprise versus last year not stated in facts.
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Oct 22, 2026Open on DART
Predicted impact: Low
- Advance Notice of Earnings Results Disclosure (Informational Disclosure)결산실적공시예고(안내공시)Oct 22, 2026Open on DART
Predicted impact: Low
- Major sales or supply contract단일판매ㆍ공급계약체결(자회사의 주요경영사항)Oct 16, 2026Open on DART
Predicted impact: Medium· Actual: +1.4% vs sector, volume 0.8× normal (5 trading days)
Subsidiary supply contract disclosed, but size not given; cannot confirm it reaches 10% of revenue.
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 8, 2026Open on DART
- Inclusion of Subsidiary into Holding Company지주회사의자회사편입Oct 2, 2026Open on DART
- Withdrawal of Subsidiary from Holding Company지주회사의자회사탈퇴Oct 2, 2026Open on DART
- Merger Completion Report (Merger)합병등종료보고서(합병)Oct 2, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Oct 2, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결(자회사의 주요경영사항)Sep 30, 2026Open on DART
- Results of Extraordinary Shareholders' Meeting임시주주총회결과Sep 22, 2026Open on DART
- Major sales or supply contract단일판매ㆍ공급계약체결(자회사의 주요경영사항)Sep 18, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Sep 7, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Sep 7, 2026Open on DART
- [Amendment] Decision on Debt Guarantee to Third Party[기재정정]타인에대한채무보증결정Sep 4, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Sep 2, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 2, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 2, 2026Open on DART
- Major sales or supply contract단일판매ㆍ공급계약체결(자회사의 주요경영사항)Aug 28, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 27, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Aug 13, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Aug 13, 2026Open on DART
- Decision on Guarantee of Debt for Another Party타인에대한채무보증결정Aug 13, 2026Open on DART
- Decision on Increase in Short-Term Borrowings (Material Management Matters of Subsidiary)단기차입금증가결정(자회사의 주요경영사항)Aug 13, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Jul 27, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Jul 27, 2026Open on DART
- Amended attachment: Merger decision[첨부정정]주요사항보고서(회사합병결정)Jul 27, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Jul 23, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Jul 23, 2026Open on DART
- Advance Notice of Earnings Results Disclosure (Informational Disclosure)결산실적공시예고(안내공시)Jul 23, 2026Open on DART
- Merger decision주요사항보고서(회사합병결정)Jul 23, 2026Open on DART
- [Attached Correction] Sustainability Report and Related Matters (Voluntary Disclosure)[첨부정정]지속가능경영보고서등관련사항(자율공시)Jul 20, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Jul 16, 2026Open on DART
- Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Jul 16, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결(자회사의 주요경영사항)Jul 10, 2026Open on DART
Titles in Korean until English translations are added.
Also known as: Dong-A Pharmaceutical / 동아제약 / 000640 / KRX:000640
Source: KRX statistical information